Effect of L-Citrulline Supplementation on NAFLD in Adolescents With Obesity
NCT04871360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2022-01-19
Summary
One of the comorbidities of obesity is nonalcoholic fatty liver disease (NAFLD). L-citrulline is a non-protein amino acid that has shown positive effects on the degree of fat retention and metabolic profile in NAFLD. The objective is to assess the effect of oral L-citrulline supplementation on liver function and nonalcoholic fatty liver in adolescents with obesity. A clinical study will be carried out in 40 adolescents (15-19 years) with obesity, they will be divided into a control group that will receive a placebo and an experimental group that will receive 6 g of l-citrulline per day for eight weeks.
Conditions
- Non-Alcoholic Fatty Liver Disease
- Obesity
Interventions
- DIETARY_SUPPLEMENT
-
L-Citrulline supplement
The intervention will consist of oral supplementation of six grams of pure l-citrulline for eight weeks.
- DIETARY_SUPPLEMENT
-
Carboxymethyl cellulose supplement
The intervention will consist of oral carboxymethyl cellulose supplementation as a placebo.
Sponsors & Collaborators
-
Universidad de Guanajuato
lead OTHER
Principal Investigators
-
Ma. E Garay-Sevilla, PhD · Universidad de Guanajuato
-
Verónica I Tovar-Villegass, Bachelor · Universidad de Guanajuato
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-05
- Primary Completion
- 2021-12-19
- Completion
- 2022-01-15
Countries
- Mexico
Study Locations
More Related Trials
-
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
NCT05897606 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917 ·Status: COMPLETED ·Phase: NA
-
Fatty Liver Disease in Obese Children
NCT02117700 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children
NCT02337894 ·Status: WITHDRAWN ·Phase: NA
-
Fructose and Liver Diseases in Youth: Help Them FLY
NCT05528471 ·Status: RECRUITING ·Phase: NA
-
Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease
NCT01553500 ·Status: COMPLETED ·Phase: PHASE2
-
High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease
NCT05578404 ·Status: COMPLETED ·Phase: PHASE2
-
Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis
NCT03312140 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT04073368 ·Status: COMPLETED ·Phase: NA
-
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT04634643 ·Status: RECRUITING
-
Effect of Polyphenol Supplementation on Hepatic Steatosis and Vascular Compliance
NCT03994029 ·Status: RECRUITING ·Phase: NA
-
Soluble Fibre Supplementation in NAFLD
NCT05480696 ·Status: RECRUITING ·Phase: PHASE2
-
A Feasibility Trial of OCM Supplements for the Treatment of NAFLD
NCT05720702 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00885313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases
NCT04475276 ·Status: COMPLETED ·Phase: PHASE4
-
Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression
NCT05291104 ·Status: COMPLETED ·Phase: NA
-
Metabolic Pathology of Pediatric NAFLD
NCT05430178 ·Status: RECRUITING ·Phase: NA
-
Effect of Ketone Esters on Liver Fat Content and Metabolic Function
NCT07097506 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver
NCT03319199 ·Status: COMPLETED ·Phase: NA
-
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07285135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Acetyl-L-carnitine on Chronic Pancreatitis
NCT02538146 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00655018 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
NCT03073343 ·Status: RECRUITING ·Phase: NA
-
Effects of Bacillus Coagulans on Liver and Gut Microbiota Function in NAFLD
NCT05635474 ·Status: UNKNOWN ·Phase: NA
-
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
NCT01529268 ·Status: COMPLETED ·Phase: PHASE2/PHASE3